Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
-Advocacy and Legislative Updates
 Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Law Signed to Improve Access to Clinical Trials
 
On October 5, 2010, the Improving Access to Clinical Trials Act (P.L. 111-255) was signed into law.  This legislation helps reduce barriers for certain people wanting to participate in clinical trials.  Often, clinical trial sponsors compensate participants financially for their time.  The money is regarded as personal income for tax purposes.  This payment, however, may threaten the eligibility of some people to be enrolled in Medicaid or to collect Supplemental Security Income.  With a small number of potential trial participants, and the possible loss of Supplemental Security Income and Medicaid benefits for many who wish to participate, clinical trial research for rare diseases and conditions becomes exceptionally difficult and may hinder research on new treatments and potential cures.  The new law will allow compensation up to $2,000 to be excluded from taxable income, thereby making it easier for people to participate in clinical trials.
 

This section of our Web site is sponsored by: